close
close

FINEARTS study has enabled refined treatment as a therapy option in HFpEF

FINEARTS study has enabled refined treatment as a therapy option in HFpEF

The Herzinsuffizienz with a slight reduction or erhaltener Ejektionsfraktion loses ihren Status as schwer treatable: After the SGLT2-Inhibitors are now still auch Finerenon as prognostic …